Figure 1.
Factor IX (F.IX) activity levels and transaminases (AST, ALT) as a function of time in weeks after vector administration in a subject with severe hemophilia B infused with 2 × 1012 vector genomes/kg of AAV-2-F.IX via the hepatic artery.
Factor IX (F.IX) activity levels and transaminases (AST, ALT) as a function of time in weeks after vector administration in a subject with severe hemophilia B infused with 2 × 1012 vector genomes/kg of AAV-2-F.IX via the hepatic artery.
